RecruitingPhase 3NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Sponsor: Eidos Therapeutics, a BridgeBio company
New York, NY · +37 more sites
1 recruiting alzheimer's disease studies with a site in Rosedale, NY.
Sponsor: Eidos Therapeutics, a BridgeBio company
New York, NY · +37 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.